A phase I study of S-1 administration and a 24-h infusion of cisplatin plus paclitaxel in patients with advanced gastric cancer

Anticancer Research

Volumn 26, Issue 2 B, 2006, Pages 1605-1609

  Iwase, Hiroaki ^a   Shimada, Masaaki ^a   Tsuzuki, Tomoyuki ^a   Okeya, Masayuki ^a   Kobayashi, Keiko ^a   Hibino, Yuichi ^a   Watanabe, Hisanori ^a   Goto, Hidemi ^b  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cisplatin; Gastric cancer; Paclitaxel; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; CISPLATIN; CREATININE; DEXAMETHASONE; DIPHENHYDRAMINE; PACLITAXEL; RANITIDINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DOSE RESPONSE; FATIGUE; FEMALE; HUMAN; INFECTION; KIDNEY FAILURE; MALE; MAXIMUM TOLERATED DOSE; MYALGIA; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; SIDE EFFECT; STOMACH CANCER; STOMATITIS; THERAPY DELAY; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; OXONIC ACID; PACLITAXEL; PILOT PROJECTS; PYRIDINES; STOMACH NEOPLASMS; TEGAFUR;

EID: 33645864355     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ohtu A, Shimada Y, Schirao K et al: Randomized phase II trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegfur plus mitomycin in patients with unresectable, advanced gastric cancer: the Japan Clinical Oncology Group Study (JCOG9205). J Clin Oncol 21: 54-59, 2003.
2. Findly M, Cunningham D, Scarffe J et al: A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol 5: 609-616, 1994.
3. Webb A, Cunningham D, Scarffe JH et al: Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer: J Clin Oncol 15: 261-267, 1997.
4. Vanhoefer U, Rougier P, Wilke H et al: Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovolin, and fluorouracil, versus infusion fluorouracil and cisplatin in advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, a comparison of 3 frequently used regimens. J Clin Oncol 18: 2648-2657, 2000.
5. Sakata Y, Ohtsu A, Horikoshi N et al: Late phase II study of novel oral fluoropyrimidine anticancer Drug S-1 (1M tegafur-0.4M gimestat-1M otastat potassium) in advanced gastric cancer patients. Eur J Cancer 34: 1715-1720, 1998.
6. Koizumi W, Kurihara M, Nakano S et al: Phase II study of S1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. Oncology 58: 191-197, 2000.
7. Koizumi W, Tanabe S, Saigenji K et al: Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer 89: 2207-2212, 2003.
8. Iwase H, Shimada M, Tsuzuki T et al: A phase II multicentric trial of S-1 combined with 24 h-infusion of cisplatin in patients with advanced gastric cancer. Anticancer Res 25: 1297-1302, 2005.
9. Japanese Research Society for Gastric Cancer: Japanese Classification of Gastric Carcinoma (English ed 1). Tokyo, Japan, Kanehara, 1995.
10. Kurihara M, Izumi T, Yoshida S et al: A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer. J Jpn Cancer Res 82: 613-620, 1991.
11. Suga S, Iwase H, Shimada M et al: Neoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatin. Intern Med 35: 930-936, 1996.
12. Ikeda N, Shimada Y, Ohtsu A et al: A phase II study of doxifluridine in elderly patients with advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG). Jan J Clin Oncol 32: 90-94, 2002
13. Koizumi W, Fukuyama Y, Fukuda T et al: Randomized phase II study comparing mitomycin, cisplatin plus doxifluridine with cisplatin plus doxifluridine in advanced unresectable gastric cancer. Anticancer Res 24: 2465-2470, 2004.
14. Ajani JA, Fairweather J, Dumas P et al: Phase II study of taxol in patients with advanced gastric carcinoma. Cancer J Sci Am 4: 269-274, 1998.
15. Vanhoefer U, Harstrick A, Wilke H et al: Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitro. Eur J Cancer 31A: 92-97, 1995.
16. Kim YH, Shin SW, Kim BS et al: Paclitaxel, 5-fluorouracil and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma. Cancer 85: 295-301, 1999.
17. Koomannsberger C, Quietzch D, Haag C et al: A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folic acid and cisplatin in patients with advanced gastric cancer. Br J Cancer 83: 458-462, 2000.
18. Honecker F, Kollmannsberger C, Quietzch D et al: Phase II study of weekly paclitaxel plus 24-h continuous infusion of 5-fluorouracil, folic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer. Anticancer Drug 13: 497-503, 2002.
19. Ajani JA, Van Cutsem E, Moiseyenko S et al: Docetaxel (D), cisplatin, and 5-fluorouracil (F) compared to cisplatin (C) and 5-fluorouracil (F) for chemotherapy naïve patients with metastatic or locally recurrent, unresectable gastric carcinoma (MGC): interim results of a randomized phase III trial (V325). Proc Am Soc Clin Oncol 22: 249, 2003.
20. Al-Batran S-E, Atmaca A, Hegewisch-Becker S et al: Phase II trial of biweekly infusion fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer. J Clin Oncol 22: 658-663, 2004.
21. Bar-Sela G, Tsalic M, Gaitini D et al: Paclitaxel, carboplatin, and oral etoposide in advanced gastric adenocarcinoma. Med Oncol 20: 291-294, 2003.